Elotuzumab Directly Enhances NK Cell Cytotoxicity Against Myeloma via CS1 Ligation: Evidence for Augmented NK Cell Function Complementing ADCC
Cancer Immunology, Immunotherapy - Germany
doi 10.1007/s00262-013-1493-8
Full Text
Open PDFAbstract
Available in full text
Date
October 26, 2013
Authors
Publisher
Springer Science and Business Media LLC